Market Overview The US market for drug delivery devices and technology was one of the most profitable and quickly growing markets in the US medical devices and healthcare fields. In 2004, it was valued approximately $65 million and has shown enormous growth over the past decade. This growth will continue over the forecast period of the next five years and into the future as new technologies are continually introduced. By 2009, the US drug delivery market will be valued at almost $140 million.
Competitors Coverage
- BD - Ypsomed - DEY - AstraZeneca - Boston Scientifi c - 3M - Cordis - AlZA - Noven - Pfeiffer - Valois - Saint-Gobain Calmar ... AND MORE!
Report Benefits
Find out how new developments in infusion affect the Drug Delivery market
Plan effective strategies with in-depth insights into: - unit volumes - average sales price - competitor market shares
Profit from new opportunities and give your company the competitive advantage
